Clinical trials
Observational Heart Arrest trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 3 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 3 |
| 2024 | 2 |
| 2025 | 5 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Recruiting | 7 |
| Unknown status | 7 |
| Not yet recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fondazione IRCCS Policlinico San Matteo di Pavia | 3 |
| University of Milano Bicocca | 3 |
| Azienda Usl di Bologna | 2 |
| Università Vita-Salute San Raffaele | 2 |
| Azienda Ospedaliera di Bolzano | 1 |
| Azienda Ospedaliero-Universitaria Careggi | 1 |
| Azienda Sanitaria Universitaria Integrata del Trentino | 1 |
| Centre Hospitalier Universitaire Vaudois | 1 |
| Centro Prevenzione Malattie Cardiovascolari N. e V. Corbella | 1 |
| Children's Hospital of Philadelphia | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heart Arrest | 24 |
| Out-of-Hospital Cardiac Arrest | 8 |
| Syncope | 3 |
| Shock, Cardiogenic | 2 |
| Syncope, Vasovagal | 2 |
| Cardiovascular Diseases | 1 |
| Coma | 1 |
| Death, Sudden, Cardiac | 1 |
| Emergencies | 1 |
| Frailty | 1 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.